Fish-skin grafts outperform current treatments in diabetic foot ulcers [Yahoo! Finance]
COLOPLAST AS SP/ADR (CLPBY)
NASDAQ:AMEX Investor Relations:
coloplast.com/investor-relations
Company Research
Source: Yahoo! Finance
Results from the study, which were published in the New England Journal of Medicine , demonstrate that the fish-skin from the Finland-based company led to significantly higher healing rates, sustained superiority, and faster healing. Kerecis's product is a fish skin sourced from Atlantic cod which, unlike other tissue-transplant options, do not contain viral transfer risk whilst still possessing regenerative properties. The prospective study (NCT04257370), named Odinn after the Norse god of healing and wisdom, is the largest randomised controlled trial of its kind because of the number of patients enrolled and severity of the wounds studied, according to Kerecis. The study compared fish-skin on 255 patients with University of Texas grade 2 and 3 diabetic foot ulcers, which are deep ulcers that penetrate to the bones and joints. Clinical sites were across France, Italy, Germany, and Sweden. After 16 weeks of treatment, Kerecis's product led to healing in 44% of patients compar
Show less
Read more
Impact Snapshot
Event Time:
CLPBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLPBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLPBY alerts
High impacting COLOPLAST AS SP/ADR news events
Weekly update
A roundup of the hottest topics
CLPBY
News
- Coloplast A/S (OTCMKTS: CLPBY) was upgraded by analysts at UBS Group AG from a "strong sell" rating to a "hold" rating.MarketBeat
- Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs [Yahoo! Finance]Yahoo! Finance
- Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs [TechCrunch]TechCrunch
- Coloplast A/S (OTCMKTS: CLPBY) was upgraded by analysts at Hsbc Global Res from a "moderate sell" rating to a "hold" rating.MarketBeat
- North America Ostomy Drainage Bags (Colostomy, Ileostomy, and Urostomy) Market Outlook 2023-2024 & 2028 with Competitive Analysis of Coloplast, ConvaTec, B. Braun, Hollister, and Salts Healthcare [Yahoo! Finance]Yahoo! Finance